Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4151031000168116 | Cytarabine (Pfizer) (cytarabine 2 g / 20 mL) injection, 1 x 20 mL vial (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4151041000168113 | Cytarabine (Pfizer) 2 g/20 mL injection, 20 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cytarabine (Pfizer) 2 g/20 mL injection, 20 mL vial | Is a | trade product pack | true | Inferred relationship | Some | ||
| Cytarabine (Pfizer) 2 g/20 mL injection, 20 mL vial | Is a | cytarabine 2 g/20 mL injection, 20 mL vial | true | Inferred relationship | Some | ||
| Cytarabine (Pfizer) 2 g/20 mL injection, 20 mL vial | has TPUU | Cytarabine (Pfizer) 2 g/20 mL injection, 20 mL vial | true | Inferred relationship | Some | 1 | |
| Cytarabine (Pfizer) 2 g/20 mL injection, 20 mL vial | has TP | Cytarabine (Pfizer) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cytarabine (Pfizer) 2 g/20 mL injection, 20 mL vial | Is a | True | Cytarabine (Pfizer) 2 g/20 mL injection, 20 mL vial | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR